REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
Portfolio Pulse from
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by Bronstein, Gewirtz & Grossman, LLC. The lawsuit alleges violations of federal securities laws for those who acquired Regeneron securities between November 2, 2023, and October 30, 2024.
March 04, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a class action lawsuit for alleged violations of federal securities laws. This could impact investor sentiment and stock price in the short term.
The announcement of a class action lawsuit against Regeneron Pharmaceuticals is likely to negatively impact the stock price in the short term due to potential legal liabilities and negative investor sentiment. The lawsuit pertains to alleged violations of federal securities laws, which can be significant for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100